Capecitabine
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Capecitabine and local guidelines before prescribing.
Mechanism
Oral prodrug of fluorouracil activated preferentially in tumour tissue.
Uses
Colorectal, breast and gastric cancer.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Hand-foot syndrome, diarrhoea, mucositis, nausea, myelosuppression, cardiotoxicity.
Interactions
Warfarin interaction with major INR rise; phenytoin levels rise; folinic acid increases toxicity.
Contraindications and cautions
DPD deficiency, severe renal impairment, concurrent warfarin
Monitoring
FBC, LFT, renal function, hand-foot skin toxicity
Pregnancy and breastfeeding
Contraindicated
Renal and hepatic impairment
Avoid if CrCl below 30
Overdose and reversal
Uridine triacetate for early severe toxicity
Special advice
Check DPD deficiency risk; monitor INR with warfarin; stop for severe diarrhoea or hand-foot reactions.
More from the textbook: uses, cautions and other points
- Chemotherapy: Capecitabine and temozolomide for pancreatic NETs. Platinum and etoposide for neuroendocrine carcinomas.
Endocrinology: NETS and Hypoglycaemia - Surgery is the only cure, but fewer than 1 in 4 tumours are resectable. Adjuvant capecitabine afterwards.
Gastroenterology: Pancreas and Biliary - Then adjuvant chemotherapy - modified FOLFIRINOX if fit, or gemcitabine with capecitabine.
Gastroenterology: Pancreas and Biliary - Antimetabolites | 5-fluorouracil and capecitabine - diarrhoea, mucositis, hand–foot syndrome , coronary vasospasm; test for DPD deficiency first (risk of fatal toxicity). Methotrexate - mucositis, kidney and liver toxicity (folinic acid rescue). Gemcitabine - flu-like symptoms, rarely HUS
Oncology: Principles - ⚠️ Safety Pearl: Chemotherapy prescribing is a specialist task, with checked protocols. Never prescribe or continue oral anti-cancer drugs (e.g. capecitabine) without clear specialist guidance - dosing errors cause serious harm.
Oncology: Principles - Hold oral chemotherapy (capecitabine).
Oncology: Emergencies
Where it is discussed in the book
- Endocrinology: NETS and Hypoglycaemia (1 mention)
- Gastroenterology: Pancreas and Biliary (3 mentions)
- Oncology: Principles (4 mentions)
- Oncology: Emergencies (1 mention)
- Oncology: Breast and Gynae Cancers (1 mention)
- Surgery: Colorectal and anal surgery (2 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (2 mentions)
- Clinical Genetics: Prenatal and newborn screening, pharmacogenomics and ethics (6 mentions)
- Biochemistry: Enzymes, vitamins and trace elements (1 mention)